• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Asthma Preventive Market Insights, Forecast to 2026

report cover
  • 19 June 2020
  • Healthcare
  • 116 Pages
  • Report Code: 24LS-8337
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Asthma Preventive -MARKET ADVISORY SERVICES

Asthma Preventive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Asthma Preventive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Asthma Preventive market is segmented into
Sodium Cromolyn
Prednisolone

Segment by Application, the Asthma Preventive market is segmented into
Children
Adult

Regional and Country-level Analysis
The Asthma Preventive market is analysed and market size information is provided by regions (countries).
The key regions covered in the Asthma Preventive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Asthma Preventive Market Share Analysis
Asthma Preventive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Asthma Preventive business, the date to enter into the Asthma Preventive market, Asthma Preventive product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Abbot
Novartis
Roche
GSK
Merck
Astrazeneca
Biotest AG
Boehringer Ingelheim
Chiesi
Sumitomo Dainippon Pharma
Amgen
1 Study Coverage
1.1 Asthma Preventive Product Introduction
1.2 Market Segments
1.3 Key Asthma Preventive Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Asthma Preventive Market Size Growth Rate by Type
1.4.2 Sodium Cromolyn
1.4.3 Prednisolone
1.5 Market by Application
1.5.1 Global Asthma Preventive Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adult
1.6 Coronavirus Disease 2019 (Covid-19): Asthma Preventive Industry Impact
1.6.1 How the Covid-19 is Affecting the Asthma Preventive Industry
1.6.1.1 Asthma Preventive Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Asthma Preventive Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Asthma Preventive Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Asthma Preventive Market Size Estimates and Forecasts
2.1.1 Global Asthma Preventive Revenue 2015-2026
2.1.2 Global Asthma Preventive Sales 2015-2026
2.2 Asthma Preventive Market Size by Region: 2020 Versus 2026
2.2.1 Global Asthma Preventive Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Asthma Preventive Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Asthma Preventive Competitor Landscape by Players
3.1 Asthma Preventive Sales by Manufacturers
3.1.1 Asthma Preventive Sales by Manufacturers (2015-2020)
3.1.2 Asthma Preventive Sales Market Share by Manufacturers (2015-2020)
3.2 Asthma Preventive Revenue by Manufacturers
3.2.1 Asthma Preventive Revenue by Manufacturers (2015-2020)
3.2.2 Asthma Preventive Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Asthma Preventive Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Asthma Preventive Revenue in 2019
3.2.5 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Asthma Preventive Price by Manufacturers
3.4 Asthma Preventive Manufacturing Base Distribution, Product Types
3.4.1 Asthma Preventive Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma Preventive Product Type
3.4.3 Date of International Manufacturers Enter into Asthma Preventive Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Asthma Preventive Market Size by Type (2015-2020)
4.1.1 Global Asthma Preventive Sales by Type (2015-2020)
4.1.2 Global Asthma Preventive Revenue by Type (2015-2020)
4.1.3 Asthma Preventive Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Asthma Preventive Market Size Forecast by Type (2021-2026)
4.2.1 Global Asthma Preventive Sales Forecast by Type (2021-2026)
4.2.2 Global Asthma Preventive Revenue Forecast by Type (2021-2026)
4.2.3 Asthma Preventive Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Asthma Preventive Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Asthma Preventive Market Size by Application (2015-2020)
5.1.1 Global Asthma Preventive Sales by Application (2015-2020)
5.1.2 Global Asthma Preventive Revenue by Application (2015-2020)
5.1.3 Asthma Preventive Price by Application (2015-2020)
5.2 Asthma Preventive Market Size Forecast by Application (2021-2026)
5.2.1 Global Asthma Preventive Sales Forecast by Application (2021-2026)
5.2.2 Global Asthma Preventive Revenue Forecast by Application (2021-2026)
5.2.3 Global Asthma Preventive Price Forecast by Application (2021-2026)

6 North America
6.1 North America Asthma Preventive by Country
6.1.1 North America Asthma Preventive Sales by Country
6.1.2 North America Asthma Preventive Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Asthma Preventive Market Facts & Figures by Type
6.3 North America Asthma Preventive Market Facts & Figures by Application

7 Europe
7.1 Europe Asthma Preventive by Country
7.1.1 Europe Asthma Preventive Sales by Country
7.1.2 Europe Asthma Preventive Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma Preventive Market Facts & Figures by Type
7.3 Europe Asthma Preventive Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Asthma Preventive by Region
8.1.1 Asia Pacific Asthma Preventive Sales by Region
8.1.2 Asia Pacific Asthma Preventive Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Asthma Preventive Market Facts & Figures by Type
8.3 Asia Pacific Asthma Preventive Market Facts & Figures by Application

9 Latin America
9.1 Latin America Asthma Preventive by Country
9.1.1 Latin America Asthma Preventive Sales by Country
9.1.2 Latin America Asthma Preventive Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Asthma Preventive Market Facts & Figures by Type
9.3 Central & South America Asthma Preventive Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Asthma Preventive by Country
10.1.1 Middle East and Africa Asthma Preventive Sales by Country
10.1.2 Middle East and Africa Asthma Preventive Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Asthma Preventive Market Facts & Figures by Type
10.3 Middle East and Africa Asthma Preventive Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Asthma Preventive Products Offered
11.1.5 Pfizer Recent Development
11.2 Abbot
11.2.1 Abbot Corporation Information
11.2.2 Abbot Description, Business Overview and Total Revenue
11.2.3 Abbot Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbot Asthma Preventive Products Offered
11.2.5 Abbot Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Asthma Preventive Products Offered
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Description, Business Overview and Total Revenue
11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche Asthma Preventive Products Offered
11.4.5 Roche Recent Development
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Description, Business Overview and Total Revenue
11.5.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GSK Asthma Preventive Products Offered
11.5.5 GSK Recent Development
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description, Business Overview and Total Revenue
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Asthma Preventive Products Offered
11.6.5 Merck Recent Development
11.7 Astrazeneca
11.7.1 Astrazeneca Corporation Information
11.7.2 Astrazeneca Description, Business Overview and Total Revenue
11.7.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Astrazeneca Asthma Preventive Products Offered
11.7.5 Astrazeneca Recent Development
11.8 Biotest AG
11.8.1 Biotest AG Corporation Information
11.8.2 Biotest AG Description, Business Overview and Total Revenue
11.8.3 Biotest AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biotest AG Asthma Preventive Products Offered
11.8.5 Biotest AG Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Boehringer Ingelheim Asthma Preventive Products Offered
11.9.5 Boehringer Ingelheim Recent Development
11.10 Chiesi
11.10.1 Chiesi Corporation Information
11.10.2 Chiesi Description, Business Overview and Total Revenue
11.10.3 Chiesi Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chiesi Asthma Preventive Products Offered
11.10.5 Chiesi Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Asthma Preventive Products Offered
11.1.5 Pfizer Recent Development
11.12 Amgen
11.12.1 Amgen Corporation Information
11.12.2 Amgen Description, Business Overview and Total Revenue
11.12.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Amgen Products Offered
11.12.5 Amgen Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Asthma Preventive Market Estimates and Projections by Region
12.1.1 Global Asthma Preventive Sales Forecast by Regions 2021-2026
12.1.2 Global Asthma Preventive Revenue Forecast by Regions 2021-2026
12.2 North America Asthma Preventive Market Size Forecast (2021-2026)
12.2.1 North America: Asthma Preventive Sales Forecast (2021-2026)
12.2.2 North America: Asthma Preventive Revenue Forecast (2021-2026)
12.2.3 North America: Asthma Preventive Market Size Forecast by Country (2021-2026)
12.3 Europe Asthma Preventive Market Size Forecast (2021-2026)
12.3.1 Europe: Asthma Preventive Sales Forecast (2021-2026)
12.3.2 Europe: Asthma Preventive Revenue Forecast (2021-2026)
12.3.3 Europe: Asthma Preventive Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Asthma Preventive Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Asthma Preventive Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Asthma Preventive Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Asthma Preventive Market Size Forecast by Region (2021-2026)
12.5 Latin America Asthma Preventive Market Size Forecast (2021-2026)
12.5.1 Latin America: Asthma Preventive Sales Forecast (2021-2026)
12.5.2 Latin America: Asthma Preventive Revenue Forecast (2021-2026)
12.5.3 Latin America: Asthma Preventive Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Asthma Preventive Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Asthma Preventive Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Asthma Preventive Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Asthma Preventive Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Asthma Preventive Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma Preventive Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables

Table 1. Asthma Preventive Market Segments

Table 2. Ranking of Global Top Asthma Preventive Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Asthma Preventive Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Sodium Cromolyn

Table 5. Major Manufacturers of Prednisolone

Table 6. COVID-19 Impact Global Market: (Four Asthma Preventive Market Size Forecast Scenarios)

Table 7. Opportunities and Trends for Asthma Preventive Players in the COVID-19 Landscape

Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 9. Key Regions/Countries Measures against Covid-19 Impact

Table 10. Proposal for Asthma Preventive Players to Combat Covid-19 Impact

Table 11. Global Asthma Preventive Market Size Growth Rate by Application 2020-2026 (K Units)

Table 12. Global Asthma Preventive Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 13. Global Asthma Preventive Sales by Regions 2015-2020 (K Units)

Table 14. Global Asthma Preventive Sales Market Share by Regions (2015-2020)

Table 15. Global Asthma Preventive Revenue by Regions 2015-2020 (US$ Million)

Table 16. Global Asthma Preventive Sales by Manufacturers (2015-2020) (K Units)

Table 17. Global Asthma Preventive Sales Share by Manufacturers (2015-2020)

Table 18. Global Asthma Preventive Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 19. Global Asthma Preventive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Preventive as of 2019)

Table 20. Asthma Preventive Revenue by Manufacturers (2015-2020) (US$ Million)

Table 21. Asthma Preventive Revenue Share by Manufacturers (2015-2020)

Table 22. Key Manufacturers Asthma Preventive Price (2015-2020) (USD/Unit)

Table 23. Asthma Preventive Manufacturers Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Asthma Preventive Product Type

Table 25. Date of International Manufacturers Enter into Asthma Preventive Market

Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 27. Global Asthma Preventive Sales by Type (2015-2020) (K Units)

Table 28. Global Asthma Preventive Sales Share by Type (2015-2020)

Table 29. Global Asthma Preventive Revenue by Type (2015-2020) (US$ Million)

Table 30. Global Asthma Preventive Revenue Share by Type (2015-2020)

Table 31. Asthma Preventive Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 32. Global Asthma Preventive Sales by Application (2015-2020) (K Units)

Table 33. Global Asthma Preventive Sales Share by Application (2015-2020)

Table 34. North America Asthma Preventive Sales by Country (2015-2020) (K Units)

Table 35. North America Asthma Preventive Sales Market Share by Country (2015-2020)

Table 36. North America Asthma Preventive Revenue by Country (2015-2020) (US$ Million)

Table 37. North America Asthma Preventive Revenue Market Share by Country (2015-2020)

Table 38. North America Asthma Preventive Sales by Type (2015-2020) (K Units)

Table 39. North America Asthma Preventive Sales Market Share by Type (2015-2020)

Table 40. North America Asthma Preventive Sales by Application (2015-2020) (K Units)

Table 41. North America Asthma Preventive Sales Market Share by Application (2015-2020)

Table 42. Europe Asthma Preventive Sales by Country (2015-2020) (K Units)

Table 43. Europe Asthma Preventive Sales Market Share by Country (2015-2020)

Table 44. Europe Asthma Preventive Revenue by Country (2015-2020) (US$ Million)

Table 45. Europe Asthma Preventive Revenue Market Share by Country (2015-2020)

Table 46. Europe Asthma Preventive Sales by Type (2015-2020) (K Units)

Table 47. Europe Asthma Preventive Sales Market Share by Type (2015-2020)

Table 48. Europe Asthma Preventive Sales by Application (2015-2020) (K Units)

Table 49. Europe Asthma Preventive Sales Market Share by Application (2015-2020)

Table 50. Asia Pacific Asthma Preventive Sales by Region (2015-2020) (K Units)

Table 51. Asia Pacific Asthma Preventive Sales Market Share by Region (2015-2020)

Table 52. Asia Pacific Asthma Preventive Revenue by Region (2015-2020) (US$ Million)

Table 53. Asia Pacific Asthma Preventive Revenue Market Share by Region (2015-2020)

Table 54. Asia Pacific Asthma Preventive Sales by Type (2015-2020) (K Units)

Table 55. Asia Pacific Asthma Preventive Sales Market Share by Type (2015-2020)

Table 56. Asia Pacific Asthma Preventive Sales by Application (2015-2020) (K Units)

Table 57. Asia Pacific Asthma Preventive Sales Market Share by Application (2015-2020)

Table 58. Latin America Asthma Preventive Sales by Country (2015-2020) (K Units)

Table 59. Latin America Asthma Preventive Sales Market Share by Country (2015-2020)

Table 60. Latin Americaa Asthma Preventive Revenue by Country (2015-2020) (US$ Million)

Table 61. Latin America Asthma Preventive Revenue Market Share by Country (2015-2020)

Table 62. Latin America Asthma Preventive Sales by Type (2015-2020) (K Units)

Table 63. Latin America Asthma Preventive Sales Market Share by Type (2015-2020)

Table 64. Latin America Asthma Preventive Sales by Application (2015-2020) (K Units)

Table 65. Latin America Asthma Preventive Sales Market Share by Application (2015-2020)

Table 66. Middle East and Africa Asthma Preventive Sales by Country (2015-2020) (K Units)

Table 67. Middle East and Africa Asthma Preventive Sales Market Share by Country (2015-2020)

Table 68. Middle East and Africa Asthma Preventive Revenue by Country (2015-2020) (US$ Million)

Table 69. Middle East and Africa Asthma Preventive Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Asthma Preventive Sales by Type (2015-2020) (K Units)

Table 71. Middle East and Africa Asthma Preventive Sales Market Share by Type (2015-2020)

Table 72. Middle East and Africa Asthma Preventive Sales by Application (2015-2020) (K Units)

Table 73. Middle East and Africa Asthma Preventive Sales Market Share by Application (2015-2020)

Table 74. Pfizer Corporation Information

Table 75. Pfizer Description and Major Businesses

Table 76. Pfizer Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. Pfizer Product

Table 78. Pfizer Recent Development

Table 79. Abbot Corporation Information

Table 80. Abbot Description and Major Businesses

Table 81. Abbot Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 82. Abbot Product

Table 83. Abbot Recent Development

Table 84. Novartis Corporation Information

Table 85. Novartis Description and Major Businesses

Table 86. Novartis Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 87. Novartis Product

Table 88. Novartis Recent Development

Table 89. Roche Corporation Information

Table 90. Roche Description and Major Businesses

Table 91. Roche Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 92. Roche Product

Table 93. Roche Recent Development

Table 94. GSK Corporation Information

Table 95. GSK Description and Major Businesses

Table 96. GSK Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 97. GSK Product

Table 98. GSK Recent Development

Table 99. Merck Corporation Information

Table 100. Merck Description and Major Businesses

Table 101. Merck Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 102. Merck Product

Table 103. Merck Recent Development

Table 104. Astrazeneca Corporation Information

Table 105. Astrazeneca Description and Major Businesses

Table 106. Astrazeneca Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 107. Astrazeneca Product

Table 108. Astrazeneca Recent Development

Table 109. Biotest AG Corporation Information

Table 110. Biotest AG Description and Major Businesses

Table 111. Biotest AG Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 112. Biotest AG Product

Table 113. Biotest AG Recent Development

Table 114. Boehringer Ingelheim Corporation Information

Table 115. Boehringer Ingelheim Description and Major Businesses

Table 116. Boehringer Ingelheim Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 117. Boehringer Ingelheim Product

Table 118. Boehringer Ingelheim Recent Development

Table 119. Chiesi Corporation Information

Table 120. Chiesi Description and Major Businesses

Table 121. Chiesi Asthma Preventive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 122. Chiesi Product

Table 123. Chiesi Recent Development

Table 124. Sumitomo Dainippon Pharma Corporation Information

Table 125. Sumitomo Dainippon Pharma Description and Major Businesses

Table 126. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 127. Sumitomo Dainippon Pharma Product

Table 128. Sumitomo Dainippon Pharma Recent Development

Table 129. Amgen Corporation Information

Table 130. Amgen Description and Major Businesses

Table 131. Amgen Asthma Preventive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 132. Amgen Product

Table 133. Amgen Recent Development

Table 134. Global Asthma Preventive Sales Forecast by Regions (2021-2026) (K Units)

Table 135. Global Asthma Preventive Sales Market Share Forecast by Regions (2021-2026)

Table 136. Global Asthma Preventive Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 137. Global Asthma Preventive Revenue Market Share Forecast by Regions (2021-2026)

Table 138. North America: Asthma Preventive Sales Forecast by Country (2021-2026) (K Units)

Table 139. North America: Asthma Preventive Revenue Forecast by Country (2021-2026) (US$ Million)

Table 140. Europe: Asthma Preventive Sales Forecast by Country (2021-2026) (K Units)

Table 141. Europe: Asthma Preventive Revenue Forecast by Country (2021-2026) (US$ Million)

Table 142. Asia Pacific: Asthma Preventive Sales Forecast by Region (2021-2026) (K Units)

Table 143. Asia Pacific: Asthma Preventive Revenue Forecast by Region (2021-2026) (US$ Million)

Table 144. Latin America: Asthma Preventive Sales Forecast by Country (2021-2026) (K Units)

Table 145. Latin America: Asthma Preventive Revenue Forecast by Country (2021-2026) (US$ Million)

Table 146. Middle East and Africa: Asthma Preventive Sales Forecast by Country (2021-2026) (K Units)

Table 147. Middle East and Africa: Asthma Preventive Revenue Forecast by Country (2021-2026) (US$ Million)

Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 149. Key Challenges

Table 150. Market Risks

Table 151. Main Points Interviewed from Key Asthma Preventive Players

Table 152. Asthma Preventive Customers List

Table 153. Asthma Preventive Distributors List

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

List of Figures

Figure 1. Asthma Preventive Product Picture

Figure 2. Global Asthma Preventive Sales Market Share by Type in 2020 & 2026

Figure 3. Sodium Cromolyn Product Picture

Figure 4. Prednisolone Product Picture

Figure 5. Global Asthma Preventive Sales Market Share by Application in 2020 & 2026

Figure 6. Children

Figure 7. Adult

Figure 8. Asthma Preventive Report Years Considered

Figure 9. Global Asthma Preventive Market Size 2015-2026 (US$ Million)

Figure 10. Global Asthma Preventive Sales 2015-2026 (K Units)

Figure 11. Global Asthma Preventive Market Size Market Share by Region: 2020 Versus 2026

Figure 12. Global Asthma Preventive Sales Market Share by Region (2015-2020)

Figure 13. Global Asthma Preventive Sales Market Share by Region in 2019

Figure 14. Global Asthma Preventive Revenue Market Share by Region (2015-2020)

Figure 15. Global Asthma Preventive Revenue Market Share by Region in 2019

Figure 16. Global Asthma Preventive Sales Share by Manufacturer in 2019

Figure 17. The Top 10 and 5 Players Market Share by Asthma Preventive Revenue in 2019

Figure 18. Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 19. Global Asthma Preventive Sales Market Share by Type (2015-2020)

Figure 20. Global Asthma Preventive Sales Market Share by Type in 2019

Figure 21. Global Asthma Preventive Revenue Market Share by Type (2015-2020)

Figure 22. Global Asthma Preventive Revenue Market Share by Type in 2019

Figure 23. Global Asthma Preventive Market Share by Price Range (2015-2020)

Figure 24. Global Asthma Preventive Sales Market Share by Application (2015-2020)

Figure 25. Global Asthma Preventive Sales Market Share by Application in 2019

Figure 26. Global Asthma Preventive Revenue Market Share by Application (2015-2020)

Figure 27. Global Asthma Preventive Revenue Market Share by Application in 2019

Figure 28. North America Asthma Preventive Sales Growth Rate 2015-2020 (K Units)

Figure 29. North America Asthma Preventive Revenue Growth Rate 2015-2020 (US$ Million)

Figure 30. North America Asthma Preventive Sales Market Share by Country in 2019

Figure 31. North America Asthma Preventive Revenue Market Share by Country in 2019

Figure 32. U.S. Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 33. U.S. Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 34. Canada Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 35. Canada Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. North America Asthma Preventive Market Share by Type in 2019

Figure 37. North America Asthma Preventive Market Share by Application in 2019

Figure 38. Europe Asthma Preventive Sales Growth Rate 2015-2020 (K Units)

Figure 39. Europe Asthma Preventive Revenue Growth Rate 2015-2020 (US$ Million)

Figure 40. Europe Asthma Preventive Sales Market Share by Country in 2019

Figure 41. Europe Asthma Preventive Revenue Market Share by Country in 2019

Figure 42. Germany Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 43. Germany Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. France Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 45. France Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. U.K. Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 47. U.K. Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. Italy Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 49. Italy Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Russia Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 51. Russia Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Europe Asthma Preventive Market Share by Type in 2019

Figure 53. Europe Asthma Preventive Market Share by Application in 2019

Figure 54. Asia Pacific Asthma Preventive Sales Growth Rate 2015-2020 (K Units)

Figure 55. Asia Pacific Asthma Preventive Revenue Growth Rate 2015-2020 (US$ Million)

Figure 56. Asia Pacific Asthma Preventive Sales Market Share by Region in 2019

Figure 57. Asia Pacific Asthma Preventive Revenue Market Share by Region in 2019

Figure 58. China Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 59. China Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Japan Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 61. Japan Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. South Korea Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 63. South Korea Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 64. India Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 65. India Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Australia Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 67. Australia Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Taiwan Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 69. Taiwan Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Indonesia Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 71. Indonesia Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Thailand Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 73. Thailand Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Malaysia Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 75. Malaysia Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Philippines Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 77. Philippines Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Vietnam Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 79. Vietnam Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Asia Pacific Asthma Preventive Market Share by Type in 2019

Figure 81. Asia Pacific Asthma Preventive Market Share by Application in 2019

Figure 82. Latin America Asthma Preventive Sales Growth Rate 2015-2020 (K Units)

Figure 83. Latin America Asthma Preventive Revenue Growth Rate 2015-2020 (US$ Million)

Figure 84. Latin America Asthma Preventive Sales Market Share by Country in 2019

Figure 85. Latin America Asthma Preventive Revenue Market Share by Country in 2019

Figure 86. Mexico Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 87. Mexico Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 88. Brazil Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 89. Brazil Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 90. Argentina Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 91. Argentina Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Latin America Asthma Preventive Market Share by Type in 2019

Figure 93. Latin America Asthma Preventive Market Share by Application in 2019

Figure 94. Middle East and Africa Asthma Preventive Sales Growth Rate 2015-2020 (K Units)

Figure 95. Middle East and Africa Asthma Preventive Revenue Growth Rate 2015-2020 (US$ Million)

Figure 96. Middle East and Africa Asthma Preventive Sales Market Share by Country in 2019

Figure 97. Middle East and Africa Asthma Preventive Revenue Market Share by Country in 2019

Figure 98. Turkey Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 99. Turkey Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 100. Saudi Arabia Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 101. Saudi Arabia Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. U.A.E Asthma Preventive Sales Growth Rate (2015-2020) (K Units)

Figure 103. U.A.E Asthma Preventive Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. Middle East and Africa Asthma Preventive Market Share by Type in 2019

Figure 105. Middle East and Africa Asthma Preventive Market Share by Application in 2019

Figure 106. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 107. Abbot Total Revenue (US$ Million): 2019 Compared with 2018

Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 109. Roche Total Revenue (US$ Million): 2019 Compared with 2018

Figure 110. GSK Total Revenue (US$ Million): 2019 Compared with 2018

Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018

Figure 112. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 113. Biotest AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 114. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018

Figure 115. Chiesi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 116. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 117. Amgen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 118. North America Asthma Preventive Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 119. North America Asthma Preventive Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 120. Europe Asthma Preventive Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 121. Europe Asthma Preventive Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 122. Asia Pacific Asthma Preventive Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 123. Asia Pacific Asthma Preventive Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 124. Latin America Asthma Preventive Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 125. Latin America Asthma Preventive Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 126. Middle East and Africa Asthma Preventive Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 127. Middle East and Africa Asthma Preventive Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 128. Porter's Five Forces Analysis

Figure 129. Channels of Distribution

Figure 130. Distributors Profiles

Figure 131. Bottom-up and Top-down Approaches for This Report

Figure 132. Data Triangulation

Figure 133. Key Executives Interviewed

Pfizer

Abbot

Novartis

Roche

GSK

Merck

Astrazeneca

Biotest AG

Boehringer Ingelheim

Chiesi

Sumitomo Dainippon Pharma

Amgen

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2964

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase